JEPQ vs VHT
JPMorgan Nasdaq Equity Premium Income ETF vs Vanguard Health Care ETF
- • VHT has the lower expense ratio at 0.09% vs 0.35% for JEPQ.
- • JEPQ pays a higher dividend yield (10.43%).
Side-by-side metrics
| Metric | JEPQ | VHT |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.35% | 0.09% |
Dividend yield Trailing 12-month yield. | 10.43% | 1.72% |
AUM Assets under management — bigger funds are typically more liquid. | $37.67B | $18.51B |
YTD return | 6.01% | -4.77% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.76 | 0.64 |
P/E ratio | 32.56 | 25.44 |
Last price | $59.38 | $271.09 |
Inception | — | — |
Issuer | JPMorgan | Vanguard |
JEPQ top holdings
| NVDA | NVIDIA Corp | 7.76% |
| AAPL | Apple Inc | 6.29% |
| GOOG | Alphabet Inc Class C | 6.28% |
| MSFT | Microsoft Corp | 4.91% |
| AMZN | Amazon.com Inc | 4.72% |
| META | Meta Platforms Inc Class A | 2.99% |
| MU | Micron Technology Inc | 2.89% |
| AVGO | Broadcom Inc | 2.78% |
| AMD | Advanced Micro Devices Inc | 2.70% |
| TSLA | Tesla Inc | 2.48% |
VHT top holdings
| LLY | Eli Lilly and Co | 11.89% |
| JNJ | Johnson & Johnson | 9.34% |
| ABBV | AbbVie Inc | 6.18% |
| MRK | Merck & Co Inc | 4.80% |
| UNH | UnitedHealth Group Inc | 3.94% |
| AMGN | Amgen Inc | 3.05% |
| TMO | Thermo Fisher Scientific Inc | 2.97% |
| ABT | Abbott Laboratories | 2.87% |
| GILD | Gilead Sciences Inc | 2.78% |
| ISRG | Intuitive Surgical Inc | 2.63% |
About JEPQ
JEPQ (JPMorgan Nasdaq Equity Premium Income ETF) is Nasdaq-tilted equity income with options overlay. Managed by JPMorgan, the fund carries $37.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 10.43%. Its largest holding is NVIDIA Corp (NVDA), which represents 7.8% of the portfolio. Real Estate is the fund's largest sector exposure at 0.2%.
About VHT
VHT (Vanguard Health Care ETF) is US health care sector stocks. Managed by Vanguard, the fund carries $18.5B in assets under management, an expense ratio of 0.09%, a dividend yield of 1.72%. Its largest holding is Eli Lilly and Co (LLY), which represents 11.9% of the portfolio. Technology is the fund's largest sector exposure at 0.0%.